Inozyme Pharma Inc.

NASDAQ: INZY
Share price (3/25/25): $0.97
Market cap (3/25/25): $62.4 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Subramanian Sanjay

Treco Douglas A

Samlyn Capital, LLC

Affinity Asset Advisors, LLC

News Filter

Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program and Recent Business Highlights

Announces Positive Interim Data for INZ-701 in Infants and Young Children With ENPP1 Deficiency and Key Program Updates

Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Announces Positive Interim Data From Phase 1 SEAPORT 1 Trial of INZ-701

Completion of Acquisition or Disposition of Assets

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC